Dr. Ganesh Raghu, MD

Dr. Raghu practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Raghu's NPI, 1821188780, was assigned on October 13, 2006. Dr. Raghu holds Washington license MD00019416.

Dr. Raghu's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Raghu's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Raghu is also affiliated with MultiCare Tacoma General Hospital. The medical group on file is UW Physicians. Dmand AI also links Dr. Raghu to 4 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raghu practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Raghu's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Raghu is licensed in Washington.

CMS data shows 1,110 Medicare services from Dr. Raghu across 6 procedure codes in 2024, for 304 Medicare patients. Medicare paid $79,138 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 304 Medicare patients who saw Dr. Raghu in 2024. The largest group is 65 to 74, with 136 patients. 65% of them have high cholesterol, and 61% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raghu's median patient age at 68, with 54% women.

In 2024, Dr. Raghu wrote 1,885 Medicare Part D claims for 250 patients. 73% of them were for generic drugs. CMS names the drug for 1,752 of them, across 24 drugs with 11 or more claims each, at $4,606,932 in total drug cost. In 2023, CMS named 1,521 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Raghu for performance year 2024, reported through an alternative payment model (APM). Dr. Raghu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raghu as offering telehealth.

Dmand AI links 272 papers to Dr. Raghu, published from 2006 to 2025. 2019 was the busiest year, with 21. The most frequent topics are Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial and Lung. Dr. Raghu has published most often in Eur Respir J. Dr. Raghu's most frequent co-authors are Kevin Robert Flaherty, MD, David Joshua Lederer, MD and Bridget F. Collins, MD.

Dmand AI links Dr. Raghu to 3 clinical trials. Conditions studied include Idiopathic Pulmonary Fibrosis, Sarcoidosis and Scleroderma, Systemic. Open Payments lists research payments to Dr. Raghu that name 1 trial.

CMS Open Payments shows 237 general payments to Dr. Raghu from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $122,980. It also lists 37 research payments totaling $36,894 from 2016 to 2025, naming 1 clinical trial.